Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior

scientific article published on 24 November 2011

Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2147/IJN.S26016
P932PMC publication ID3230569
P698PubMed publication ID22162659

P50authorDimitrios N BikiarisQ63993390
Dimitrios J GiliopoulosQ88943056
Evangelos KaravasQ123562021
Vassilios KaravelidisQ123562029
P2093author name stringSofia Papadimitriou
P2860cites workNanotechnology: intelligent design to treat complex diseaseQ28246583
Novel biodegradable polyesters. Synthesis and application as drug carriers for the preparation of raloxifene HCl loaded nanoparticles.Q33487116
Long-circulating and target-specific nanoparticles: theory to practiceQ34253450
Polymers in drug deliveryQ34318090
Biodegradable nanoparticles for drug and gene delivery to cells and tissueQ35082117
Polymer architecture and drug deliveryQ36360121
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosisQ36537033
Nanocarriers: promising vehicle for bioactive drugsQ36583337
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.Q36627730
Micellar nanocarriers: pharmaceutical perspectivesQ36655007
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.Q36733054
Engineering biodegradable polyester particles with specific drug targeting and drug release propertiesQ36920273
Methods for the preparation and manufacture of polymeric nanoparticles.Q37358092
Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrixQ38549183
Biodegradable long-circulating polymeric nanospheresQ38569096
Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug releaseQ39850721
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymersQ40961272
Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriersQ42876909
Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behaviorQ42878158
Effectiveness of various drug carriers in controlled release formulations of raloxifene HCl prepared by melt mixingQ43277074
Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micellesQ44062866
Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in miceQ44828772
Correlation between chemical and solid-state structures and enzymatic hydrolysis in novel biodegradable polyesters. The case of poly(propylene alkanedicarboxylate)sQ46161739
Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivoQ47297862
Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheresQ51809991
Synthesis, cocrystallization, and enzymatic degradation of novel poly(butylene-co-propylene succinate) copolymersQ57186886
Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterizationQ74825559
Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrixQ78225522
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectnanocarrierQ17153796
P304page(s)3021-3032
P577publication date2011-11-24
P1433published inInternational Journal of NanomedicineQ6051502
P1476titleEvaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior
P478volume6

Reverse relations

cites work (P2860)
Q58557425Amphiphilic Block Copolymer Microspheres Derived from Castor Oil, Poly(ε-carpolactone), and Poly(ethylene glycol): Preparation, Characterization and Application in Naltrexone Drug Delivery
Q57793210Cationic Substitutions in Hydroxyapatite: Current Status of the Derived Biofunctional Effects and Their In Vitro Interrogation Methods
Q58696457Chitosan Nanoparticles with Encapsulated Natural and UF-Purified Annatto and Saffron for the Preparation of UV Protective Cosmetic Emulsions
Q33902253Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.
Q26782780Drug Carrier for Photodynamic Cancer Therapy
Q52601406Drug delivery systems and materials for wound healing applications.
Q36176104Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles
Q36079945Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2.
Q35100738Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells
Q93081684Selectively Biodegradable Polyesters: Nature-Inspired Construction Materials for Future Biomedical Applications
Q38821629Synthesis of folate- pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells
Q38643438Thermomechanical Properties of Polylactic Acid-Graphene Composites: A State-of-the-Art Review for Biomedical Applications

Search more.